The flow cytometry market size has grown rapidly in recent years. It will grow from $7.49 billion in 2025 to $8.34 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to growth in biomedical research, expansion of cancer diagnostics, availability of advanced cytometers, increased funding for life sciences, rising demand for cell-based analysis.
The flow cytometry market size is expected to see rapid growth in the next few years. It will grow to $12.79 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to integration of ai-driven analytics, growth in precision medicine research, expansion of stem cell therapies, increased pharmaceutical r&d investment, demand for high-throughput analysis. Major trends in the forecast period include growing adoption in clinical diagnostics, increased demand for multi-parameter cell analysis, expansion of flow cytometry in drug discovery, rising use in immunology and hematology research, integration of advanced data analysis software.
The rising number of HIV cases worldwide is expected to drive growth in the flow cytometry market. This is because flow cytometry is directly used in the diagnosis of HIV. The technique employs light scattering to identify cells, which are tagged with specific markers known as CDs (clusters of differentiation) according to their scattering properties. For example, in July 2024, UNAIDS, a Switzerland-based UN program, reported that in 2023 approximately 39.9 million people were living with HIV globally, up from 39.0 million in 2022. Therefore, the growing prevalence of HIV is propelling the flow cytometry market.
Key players in the flow cytometry market are focusing on innovations such as automated sample preparation systems to deliver faster, more accurate results while minimizing hands-on time for laboratory technicians. An automated sample preparation system streamlines laboratory workflows by automating tasks like mixing, staining, and dilution, ensuring consistent and precise sample preparation. This reduces manual labor and improves efficiency, making it especially suitable for high-throughput labs and clinical diagnostics. For instance, in June 2023, Becton, Dickinson, and Company, a US-based medical device firm, launched the BD FACSDuet, a premium sample preparation system designed to integrate seamlessly with the BD FACSLyric clinical flow cytometry system. It provides a fully automated 'walkaway' workflow, handling key processes such as cocktailing, washing, and centrifuging samples, which are then transferred to the flow cytometer without human intervention. This system enhances standardization, reproducibility, and overall lab efficiency in clinical diagnostics.
In February 2023, Cytek Biosciences, a US-based provider of high-parameter flow cytometry instruments, reagents, software, and cell-analysis solutions, acquired Luminex Corporation’s Flow Cytometry & Imaging (FCI) business unit for an undisclosed amount. This acquisition enabled Cytek to expand its portfolio to include imaging flow cytometry and menu-driven, application-specific cytometry, offering a more comprehensive cell analysis platform. Luminex Corporation is a US-based company providing conventional and image-based flow cytometry instruments, reagents, and related services.
Major companies operating in the flow cytometry market are Beckman Coulter Inc., Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Luminex Corporation, Miltenyi Biotec Ltd., Becton Dickinson and Company, Danaher Corporation, Apogee Flow Systems Ltd., Stratedigm Inc., EMD Millipore Corporation, Cytonome St LLC, Enzo Life Sciences Inc., Sony Biotechnology Inc., Life Technologies Corporation, ACEA Biosciences Inc., Takara Bio Inc., Union Biometrica Inc., Cytek Biosciences Inc., Nexcelom Bioscience LLC, Verity Software House Inc., Spectral Cytometry Systems GmbH, InstruNor AS.
North America was the largest region in the flow cytometry market in 2025. Western Europe was the second largest region in the flow cytometry market analysis. The regions covered in the flow cytometry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the flow cytometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the flow cytometry market by increasing the cost of imported lasers, optics, reagents, assay kits, and analytical instruments. Research institutes, hospitals, and pharmaceutical companies in Asia-Pacific and Europe are most affected due to reliance on global laboratory equipment suppliers. These higher costs can slow research and diagnostic expansion. However, tariffs are encouraging regional manufacturing of reagents and instruments, improving long-term technology access.
The flow cytometry market research report is one of a series of new reports that provides flow cytometry market statistics, including flow cytometry industry global market size, regional shares, competitors with a flow cytometry market share, detailed flow cytometry market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry industry. This flow cytometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Flow cytometry is a technique in which cells are suspended in a fluid medium and passed through a pulsating laser beam. As the cells scatter the laser light in various directions, detectors capture the signals and convert them into data displayed on a monitor. This method is used to analyze biological cell characteristics, including cell size, count, and complexity, using laser optics.
The main components of flow cytometry include instruments, reagents and consumables, software, accessories, and services. Flow cytometry services encompass experimental design, specimen processing, data acquisition, and analysis, supporting researchers, biotech firms, and pharmaceutical companies in drug development. The technologies used are cell-based and bead-based, with applications in oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, and hematology. Key end users include hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, and other healthcare and research organizations.
The flow cytometry market includes revenue earned by cytometry systems, panel builders, and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The flow cytometry market size is expected to see rapid growth in the next few years. It will grow to $12.79 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to integration of ai-driven analytics, growth in precision medicine research, expansion of stem cell therapies, increased pharmaceutical r&d investment, demand for high-throughput analysis. Major trends in the forecast period include growing adoption in clinical diagnostics, increased demand for multi-parameter cell analysis, expansion of flow cytometry in drug discovery, rising use in immunology and hematology research, integration of advanced data analysis software.
The rising number of HIV cases worldwide is expected to drive growth in the flow cytometry market. This is because flow cytometry is directly used in the diagnosis of HIV. The technique employs light scattering to identify cells, which are tagged with specific markers known as CDs (clusters of differentiation) according to their scattering properties. For example, in July 2024, UNAIDS, a Switzerland-based UN program, reported that in 2023 approximately 39.9 million people were living with HIV globally, up from 39.0 million in 2022. Therefore, the growing prevalence of HIV is propelling the flow cytometry market.
Key players in the flow cytometry market are focusing on innovations such as automated sample preparation systems to deliver faster, more accurate results while minimizing hands-on time for laboratory technicians. An automated sample preparation system streamlines laboratory workflows by automating tasks like mixing, staining, and dilution, ensuring consistent and precise sample preparation. This reduces manual labor and improves efficiency, making it especially suitable for high-throughput labs and clinical diagnostics. For instance, in June 2023, Becton, Dickinson, and Company, a US-based medical device firm, launched the BD FACSDuet, a premium sample preparation system designed to integrate seamlessly with the BD FACSLyric clinical flow cytometry system. It provides a fully automated 'walkaway' workflow, handling key processes such as cocktailing, washing, and centrifuging samples, which are then transferred to the flow cytometer without human intervention. This system enhances standardization, reproducibility, and overall lab efficiency in clinical diagnostics.
In February 2023, Cytek Biosciences, a US-based provider of high-parameter flow cytometry instruments, reagents, software, and cell-analysis solutions, acquired Luminex Corporation’s Flow Cytometry & Imaging (FCI) business unit for an undisclosed amount. This acquisition enabled Cytek to expand its portfolio to include imaging flow cytometry and menu-driven, application-specific cytometry, offering a more comprehensive cell analysis platform. Luminex Corporation is a US-based company providing conventional and image-based flow cytometry instruments, reagents, and related services.
Major companies operating in the flow cytometry market are Beckman Coulter Inc., Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Luminex Corporation, Miltenyi Biotec Ltd., Becton Dickinson and Company, Danaher Corporation, Apogee Flow Systems Ltd., Stratedigm Inc., EMD Millipore Corporation, Cytonome St LLC, Enzo Life Sciences Inc., Sony Biotechnology Inc., Life Technologies Corporation, ACEA Biosciences Inc., Takara Bio Inc., Union Biometrica Inc., Cytek Biosciences Inc., Nexcelom Bioscience LLC, Verity Software House Inc., Spectral Cytometry Systems GmbH, InstruNor AS.
North America was the largest region in the flow cytometry market in 2025. Western Europe was the second largest region in the flow cytometry market analysis. The regions covered in the flow cytometry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the flow cytometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the flow cytometry market by increasing the cost of imported lasers, optics, reagents, assay kits, and analytical instruments. Research institutes, hospitals, and pharmaceutical companies in Asia-Pacific and Europe are most affected due to reliance on global laboratory equipment suppliers. These higher costs can slow research and diagnostic expansion. However, tariffs are encouraging regional manufacturing of reagents and instruments, improving long-term technology access.
The flow cytometry market research report is one of a series of new reports that provides flow cytometry market statistics, including flow cytometry industry global market size, regional shares, competitors with a flow cytometry market share, detailed flow cytometry market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry industry. This flow cytometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Flow cytometry is a technique in which cells are suspended in a fluid medium and passed through a pulsating laser beam. As the cells scatter the laser light in various directions, detectors capture the signals and convert them into data displayed on a monitor. This method is used to analyze biological cell characteristics, including cell size, count, and complexity, using laser optics.
The main components of flow cytometry include instruments, reagents and consumables, software, accessories, and services. Flow cytometry services encompass experimental design, specimen processing, data acquisition, and analysis, supporting researchers, biotech firms, and pharmaceutical companies in drug development. The technologies used are cell-based and bead-based, with applications in oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, and hematology. Key end users include hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, and other healthcare and research organizations.
The flow cytometry market includes revenue earned by cytometry systems, panel builders, and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Flow Cytometry Market Characteristics
3. Flow Cytometry Market Supply Chain Analysis
4. Global Flow Cytometry Market Trends and Strategies
5. Flow Cytometry Market Analysis of End Use Industries
7. Global Flow Cytometry Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Flow Cytometry Total Addressable Market (TAM) Analysis for the Market
9. Flow Cytometry Market Segmentation
10. Flow Cytometry Market Regional and Country Analysis
11. Asia-Pacific Flow Cytometry Market
12. China Flow Cytometry Market
13. India Flow Cytometry Market
14. Japan Flow Cytometry Market
15. Australia Flow Cytometry Market
16. Indonesia Flow Cytometry Market
17. South Korea Flow Cytometry Market
18. Taiwan Flow Cytometry Market
19. South East Asia Flow Cytometry Market
20. Western Europe Flow Cytometry Market
21. UK Flow Cytometry Market
22. Germany Flow Cytometry Market
23. France Flow Cytometry Market
24. Italy Flow Cytometry Market
25. Spain Flow Cytometry Market
26. Eastern Europe Flow Cytometry Market
27. Russia Flow Cytometry Market
28. North America Flow Cytometry Market
29. USA Flow Cytometry Market
30. Canada Flow Cytometry Market
31. South America Flow Cytometry Market
32. Brazil Flow Cytometry Market
33. Middle East Flow Cytometry Market
34. Africa Flow Cytometry Market
36. Flow Cytometry Market Competitive Landscape and Company Profiles
37. Flow Cytometry Market Other Major and Innovative Companies
40. Flow Cytometry Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Flow Cytometry Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses flow cytometry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for flow cytometry? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The flow cytometry market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Instruments; Reagents And Consumables; Software; Accessories; Services2) By Technology: Cell-Based; Bead-Based
3) By Application: Oncology; Drug Discovery; Disease Diagnosis; Stem Cell Therapy; Organ Transplantation; Hematology
4) By End User: Hospitals And Clinics; Academia And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Instruments: Cell Analyzers; Cell Sorters; Multi-Parameter Flow Cytometers; High-Throughput Flow Cytometers2) By Reagents And Consumables: Antibodies; Dyes And Fluorescent Probes; Kits And Assays; Sample Preparation Consumables (Tubes, Filters)
3) By Software: Data Analysis Software; Visualization Software; Acquisition Software; Cell Sorting Software
4) By Accessories: Lasers And Optics; Filters; Flow Cells; Sample Preparation Tools
5) By Services: Maintenance And Repair Services; Calibration And Validation Services; Training And Support Services
Companies Mentioned: Beckman Coulter Inc.; Bio-Rad Laboratories Inc; Thermo Fisher Scientific Inc.; Luminex Corporation; Miltenyi Biotec Ltd.; Becton Dickinson and Company; Danaher Corporation; Apogee Flow Systems Ltd.; Stratedigm Inc.; EMD Millipore Corporation; Cytonome St LLC; Enzo Life Sciences Inc.; Sony Biotechnology Inc.; Life Technologies Corporation; ACEA Biosciences Inc.; Takara Bio Inc.; Union Biometrica Inc.; Cytek Biosciences Inc.; Nexcelom Bioscience LLC; Verity Software House Inc.; Spectral Cytometry Systems GmbH; InstruNor AS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Flow Cytometry market report include:- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc.
- Luminex Corporation
- Miltenyi Biotec Ltd.
- Becton Dickinson and Company
- Danaher Corporation
- Apogee Flow Systems Ltd.
- Stratedigm Inc.
- EMD Millipore Corporation
- Cytonome St LLC
- Enzo Life Sciences Inc.
- Sony Biotechnology Inc.
- Life Technologies Corporation
- ACEA Biosciences Inc.
- Takara Bio Inc.
- Union Biometrica Inc.
- Cytek Biosciences Inc.
- Nexcelom Bioscience LLC
- Verity Software House Inc.
- Spectral Cytometry Systems GmbH
- InstruNor AS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.34 Billion |
| Forecasted Market Value ( USD | $ 12.79 Billion |
| Compound Annual Growth Rate | 11.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
